P15-12. Community advisory boards' successes and challenges in AIDS vaccine clinical trials: a Southern Africa experience by Mokhele, T
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
P15-12. Community advisory boards' successes and challenges in 
AIDS vaccine clinical trials: a Southern Africa experience
TM o k h e l e
Address: Country and Regional Programme, IAVI – Southern Africa Regional Office, North Riding, South Africa
Background
This paper presents the successes and challenges experi-
enced by Community Advisory Boards (CABs) across
AIDS vaccine Clinical Research Centers (CRCs) collabo-
rating with the International AIDS Vaccine Initiative
(IAVI) in Southern Africa. CABs serve as a link between
researchers and the community where research is taking
place.
Methods
Since 2006, IAVI has conducted 15 needs assessment ses-
sions with 13 different CABs from South Africa and Zam-
bia. Based on the findings, a CAB skills building program
was developed, three regional CAB exchange meetings
were held and 11 interactive skills building sessions were
conducted. These sessions provided a platform for CABs
to discuss and address CAB capacity building needs, chal-
lenges and successes, while considering their diversity and
the need to adapt best practices to local contexts. These
meetings also sought to address major challenges identi-
fied by CABs, such as reaching out to different communi-
ties, inconsistent capacity building efforts, unclear roles
and responsibilities, language barriers, lack of proper
understanding of scientific concepts, inadequate co-ordi-
nation and planning of CAB activities, inadequate induc-
tion of new CAB members and poor retention of CAB
members. Based on the successes and effective actions
reported by participants, best practices were identified and
shared.
Results
The skills building and exchange efforts were acknowl-
edged as contributing to build mutually beneficial rela-
tionships between CABs and research teams, to establish
community trust and ultimately to a smooth implementa-
tion of research programs. By providing opportunities for
exchange and capacity building across sites at the regional
level, the process also has contributed to strengthen
national/regional benchmarks for community engage-
ment and CABs.
Conclusion
Regular technical support of CRCs and CABs contributes
positively towards improved functioning of CABs and fur-
ther contributes to ensuring meaningful community par-
ticipation in clinical trials.
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